The year 2025 started on a strong note for Tjoapack with the successful implementation of its first Pre-Filled Syringe (PFS) project at its Dutch facility. This milestone marks a major step in expanding our packaging capabilities to meet the increasing demand for patient-centric pharmaceutical solutions.
A New Chapter in Pharmaceutical Packaging
Tjoapack, a leading provider of packaging services for the pharmaceutical industry, has officially launched its first PFS production project. This advancement underscores our commitment to innovation and flexibility in addressing the evolving needs of the pharmaceutical sector.
Our new PFS capabilities include:
With this advanced infrastructure, we are positioned to enhance both supply chain efficiency and product scalability, providing solutions that align with market demands and regulatory requirements.
A Vision for the Future
Jurgen Flohr, Derictor Operations at Tjoapack, shared his perspective on this achievement:
"The launch of our new production line for pre-filled syringes marks a major milestone in meeting the growing demand for high-quality, patient-centric pharmaceutical solutions. This expansion not only enhances our manufacturing capacity but also addresses key challenges in the market, such as scalability, supply chain efficiency, and regulatory compliance. As companies face increasing pressure to ensure consistent supply and cost efficiency, our expertise and capabilities position us as a trusted partner, delivering innovation and reliability in a competitive landscape."
As the PFS market grows, Tjoapack’s successful execution of this project further solidifies our position as a key player in pharmaceutical packaging. We are excited to continue supporting the industry with advanced solutions that drive efficiency, quality, and patient safety.
Ready to shape the future of your pharmaceutical supply chain?
